| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2862284 | 09/30/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Pain, Vaccination failure
Herpes zoster, Pain, Vaccination failure
|
Suspected vaccination failure; I had the shots and shingles twice; First time nothing much; second t...
Suspected vaccination failure; I had the shots and shingles twice; First time nothing much; second time wanted to die from the agony; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I had the shots and shingles twice) and feeling abnormal (Verbatim: First time nothing much; second time wanted to die from the agony). The outcome of the vaccination failure, shingles and feeling abnormal were not reported. It was unknown if the reporter considered the vaccination failure, shingles and feeling abnormal to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles and feeling abnormal to be related to Shingles vaccine. Additional Information: GSK receipt date: 23-SEP-2025 This case was reported by a patient via interactive digital media.; Sender's Comments: A case of Vaccination failure, unknown time after receiving unknown dose of Shingles vaccine in a subject. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.
More
|
|||||||||
| 2862285 | F | 09/30/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Herpes zoster
Herpes zoster
|
was diagnosed with shingles; This non-serious case was reported by a consumer via interactive digita...
was diagnosed with shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: was diagnosed with shingles). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 23-SEP-2025 This case was reported by a patient via interactive digital media. The patient had both shots and was diagnosed with shingles. Now the patient was in fourth week and shingles was so painful.; Sender's Comments: US-GSK-US2025AMR124431:Same patient 2nd dose
More
|
||||||||
| 2862286 | 09/30/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
Suspected Vaccination failure; shingles; This serious case was reported by a consumer via interacti...
Suspected Vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 25-SEP-2025 This case was reported by a patient via interactive digital media. The reporter reported that vaccine did not stop from getting shingles. The reporter got the vaccination and have shingles now. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: A case of Vaccination failure, unknown time after receiving Shingles vaccine in a patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.
More
|
|||||||||
| 2862287 | F | 09/30/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Injection site pain
Injection site pain
|
soreness at the site; This non-serious case was reported by a consumer via interactive digital media...
soreness at the site; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: soreness at the site). The outcome of the injection site pain was resolved. The reporter considered the injection site pain to be related to Shingrix. The company considered the injection site pain to be related to Shingrix. Additional Information: GSK Receipt Date: 24-SEP-2025 The patient only had arm soreness at the site with the first one, like a tetanus shot, so she was not prepared. The patient have since learned it was very common and just shows that it was working by stimulating immune response. Having had three bouts of shingles that progressively got worse, the one day of discomfort was worth it. This case is linked with US2025AMR124606, reported by same reporter.; Sender's Comments: US-GSK-US2025AMR124606:same reporter US-GSK-US2025AMR124423:same reporter diff dose US-GSK-US2025AMR124422:same reporter diff dose
More
|
||||||||
| 2862288 | 51 | F | TX | 09/30/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Influenza like illness, Pain, Pyrexia
Influenza like illness, Pain, Pyrexia
|
Flu-like symptoms; Fever; Body aches; This non-serious case was reported by a pharmacist via call ce...
Flu-like symptoms; Fever; Body aches; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 15-SEP-2022, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: Flu-like symptoms), fever (Verbatim: Fever) and general body pain (Verbatim: Body aches). The outcome of the influenza-like symptoms, fever and general body pain were unknown. It was unknown if the reporter considered the influenza-like symptoms, fever and general body pain to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms, fever and general body pain to be related to Shingrix. Additional Information: GSK Receipt Date: 11-SEP-2025 The pharmacy manager called to inform that a patient got the first dose of Shingrix in 2022 and the patient had experienced flu-like symptoms, fever and body aches, that is why patient did not want the second dose right away. Can patient get the second dose now or does she need to restart the series. After receiving information from MIS, HCP asked the following if a patient had side effects on the first dose, will they experience the same on the second dose.
More
|
||||||
| 2862289 | 18 | F | 09/30/2025 |
COVID19 |
MODERNA |
|
Thrombosis
Thrombosis
|
Blood clots from this vaccine; This spontaneous case was reported by a consumer and describes the oc...
Blood clots from this vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Blood clots from this vaccine) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Blood clots from this vaccine) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Blood clots from this vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Reporter was asking from this vaccine could you get blood clots and mentioned that the patient was 18 years old. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 17-Jul-2021: Upon internal review significant corrections were performed on 29-Aug-2025 after which the case was reassessed and determined to be valid. Patient details added, event verbatim updated.; Reporter's Comments: Company Comment: The benefit-risk relationship of product is not affected by this report.
More
|
|||||||
| 2862290 | 09/30/2025 |
COVID19 |
MODERNA |
Unknown |
Pain in extremity
Pain in extremity
|
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN E...
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication was not reported. Patient received the first dose of the Moderna COVID-19 vaccine about two weeks ago and had a sore arm. Patient was expected to receive the second dose sometime in Sep-2021. Patient had received first dose of the Moderna vaccine and wants to know if it is safe to travel in various scenarios also patient wants to know what to expect with the second dose of the Moderna vaccine. Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 28-Aug-2021: Upon internal review significant corrections were performed on 29-Sep-2025 after which the case was reassessed and determined to be valid. event coding updated, suspect details updated, causality added, narrative updated.
More
|
|||||||||
| 2862291 | F | 09/30/2025 |
COVID19 |
MODERNA |
|
Rheumatoid arthritis
Rheumatoid arthritis
|
strong RA flare side effects to Moderna previously; This spontaneous case was reported by a consumer...
strong RA flare side effects to Moderna previously; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (strong RA flare side effects to Moderna previously) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (strong RA flare side effects to Moderna previously) (seriousness criterion medically significant). At the time of the report, RHEUMATOID ARTHRITIS (strong RA flare side effects to Moderna previously) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medication was reported. They just wanted to notify that the Pfizer Covid vaccine patient had a week ago. Reporter saw the Finnish had noticed this in patients so wanted to let know. Maybe learning why that flared can lead to an understanding of menieres that can lead to medications that help. It was a debilitating condition. Reporter just wanted to give a heads up. It was stated that patient had strong RA flare side effects to Moderna previously and did great with yours. No treatment information was reported.; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.
More
|
||||||||
| 2862292 | 82 | F | MA | 09/30/2025 |
COVID19 |
MODERNA |
|
Electrocardiogram, Pain in extremity
Electrocardiogram, Pain in extremity
|
sore upper arm for a couple of days; This spontaneous case was reported by a consumer and describes ...
sore upper arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore upper arm for a couple of days) in an 82-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Iritis, Arthritis, Spinal stenosis, Allergy to animals (dog and cat), Grass allergy (various grasses), IBD and Colitis. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore upper arm for a couple of days). At the time of the report, PAIN IN EXTREMITY (sore upper arm for a couple of days) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: showed something with the left ventricle possible causes, had either IBD or colitis. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medications were reported. It was reported that the patient had iritis so she must take ketorolac. She had to get a stress test because the EKG showed something with the left ventricle possible causes. She was putting off the stress test because there was a 1 in 5000 risk of dying from the test. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided. This case was linked to MOD-2025-789601 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 22-Sep-2025: Live non-significant follow-up received included reference numbers were added.
More
|
||||||
| 2862293 | M | 09/30/2025 |
COVID19 |
MODERNA |
|
Immunisation reaction, Speech disorder
Immunisation reaction, Speech disorder
|
he knows he affected the matter the vaccines affect him; You can hear how he talks. He cannot talk; ...
he knows he affected the matter the vaccines affect him; You can hear how he talks. He cannot talk; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (he knows he affected the matter the vaccines affect him) and SPEECH DISORDER (You can hear how he talks. He cannot talk) in a male patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (he knows he affected the matter the vaccines affect him) and SPEECH DISORDER (You can hear how he talks. He cannot talk). At the time of the report, IMMUNISATION REACTION (he knows he affected the matter the vaccines affect him) and SPEECH DISORDER (You can hear how he talks. He cannot talk) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. Concomitant medication was not provided. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-789631 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-789631:Master case
More
|
||||||||
| 2862294 | 74 | F | 09/30/2025 |
COVID19-2 |
MODERNA |
|
Vomiting
Vomiting
|
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING ...
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The patient's past medical history included CAPD (CAPD (dialysis)) since an unknown date. Concurrent medical conditions included Type I diabetes mellitus. On 15-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In January 2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced VOMITING (Vomiting). In January 2023, VOMITING (Vomiting) had resolved. No concomitant medications were provided. It was reported that patient had taken all Covid vaccines since 2021 till now, which was 7-8 vaccines. It was reported that at each time almost 10 hours after the vaccine she would start vomiting every 20 to 30 minutes and this would last for 6-8 hours. The patient received the Moderna COVID-19 vaccine in 2021. On 28-Apr-2022, patient received a 0.5 mL dose of the Moderna COVID-19 Vaccine Booster. Patient had other 4 vaccines (Spikevax NOS), but she had no information about them. It was mentioned that she had diabetes type 1 and was on dialysis (CAPD). No treatment medication was provided. This case was linked to MOD-2025-789725 (Patient Link).
More
|
|||||||
| 2862295 | 75 | F | 09/30/2025 |
COVID19 |
MODERNA |
|
Vomiting
Vomiting
|
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING ...
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) for COVID-19 prophylaxis. The patient's past medical history included CAPD (CAPD (dialysis)) since an unknown date. Concurrent medical conditions included Type 1 diabetes mellitus. On 19-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) 1 dosage form. In October 2023, after starting mRNA-1273.815 (SPIKEVAX 2023-2024 PFS), the patient experienced VOMITING (Vomiting). In October 2023, VOMITING (Vomiting) had resolved. No concomitant medications were provided. It was reported that patient had taken all Covid vaccines since 2021 till now, which was 7-8 vaccines. It was reported that at each time almost 10 hours after the vaccine she would start vomiting every 20 to 30 minutes and this would last for 6-8 hours. It was reported that she had always taken Moderna vaccines. The patient received the Moderna COVID-19 vaccine in 2021. On 28-Apr-2022, patient received a 0.5 mL dose of the Moderna COVID-19 Vaccine Booster. On 15-Jan-2023, the patient was administered the Moderna COVID-19 Bivalent Vaccine. Patient had received other 4 vaccines (Spikevax NOS), but she had no information about them. It was mentioned that she had diabetes type 1 and was on dialysis (CAPD). No treatment medication was provided. This case was linked to MOD-2025-789725 (Patient Link).
More
|
|||||||
| 2862296 | 76 | F | 09/30/2025 |
COVID19 |
MODERNA |
|
Vomiting
Vomiting
|
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING ...
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a female patient of an unknown age who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. The patient's past medical history included CAPD (CAPD (dialysis)) since an unknown date. Concurrent medical conditions included Type 1 diabetes mellitus (Type1 diabetes). On 24-Sep-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) .5 milliliter. In September 2024, the patient experienced VOMITING (Vomiting). In September 2024, VOMITING (Vomiting) had resolved. No concomitant medications provided by the reporter. The patient received the Moderna COVID-19 vaccine in 2021. On 28-Apr-2022, patient received a 0.5 mL dose of the Moderna COVID-19 Vaccine Booster. On 15-Jan-2023, the patient was administered the Moderna COVID-19 Bivalent Vaccine. Subsequently, on 19-Oct-2023, patient received the Spikevax 2023-2024 PFS and SPIKEVAX NOS on an unknown date. It was reported that patient received all COVID-19 vaccines since 2021 till now, which was 7-8 vaccines. It was reported that post COVID-19 vaccination each time almost 10 hours after the vaccine the patient used to start vomit for every 20 to 30 minutes and that vomit used to last for 6-8 hours for the patient. It was reported that patient used to receive Moderna vaccines except for once she got Pfizer Covid-19 vaccine, but she experienced the same symptom. In addition, there were for other 4 other Moderna -Covid-19 vaccine patient had no information. No treatment medications provided by the reporter. This case was linked to MOD-2025-789725 (Patient Link).
More
|
|||||||
| 2862297 | F | 09/30/2025 |
COVID19 COVID19 |
MODERNA PFIZER\BIONTECH |
|
Vomiting; Vomiting
Vomiting; Vomiting
|
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING ...
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in an elderly female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Co-suspect product included non-company product Tozinameran (Pfizer BioNTech COVID-19 vaccine) for an unknown indication. The patient's past medical history included CAPD (CAPD (dialysis)) since an unknown date. Concurrent medical conditions included Type 1 diabetes mellitus (Type 1 diabetes). On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form and dose of Tozinameran (Pfizer BioNTech COVID-19 vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (Vomiting). At the time of the report, VOMITING (Vomiting) had resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medications provided by the reporter. The patient received the Moderna COVID-19 vaccine in 2021. On 28-Apr-2022, patient received a 0.5 mL dose of the Moderna COVID-19 Vaccine Booster. On 15-Jan-2023, the patient was administered the Moderna COVID-19 Bivalent Vaccine. Subsequently, on 19-Oct-2023, patient received the Spikevax 2023-2024 PFS and on 24-Sep-2024 patient received the SPIKEVAX 2024-2025 PFS. It was reported that patient received all Covid vaccines since 2021 till now, which was 7-8 vaccines. It was reported that post COVID-19 vaccination each time almost 10 hours after the vaccine the patient used to start vomit for every 20 to 30 minutes and that vomit used to last for 6-8 hours for the patient. It was reported that patient used to receive Moderna vaccines except for once she got Pfizer but experienced the same symptom. In addition, there were for other 4 other Moderna -Covid-19 vaccine patient had no information. No treatment medications provided by the reporter. This case was linked to MOD-2025-789725 (Patient Link).
More
|
||||||||
| 2862298 | 19 | F | MS | 09/30/2025 |
COVID19 |
PFIZER\BIONTECH |
ff2589 |
Abortion spontaneous, Exposure during pregnancy, Haemorrhage in pregnancy, Human...
Abortion spontaneous, Exposure during pregnancy, Haemorrhage in pregnancy, Human chorionic gonadotropin, Muscle spasms
More
|
Miscarriage of a 9 week pregnancy on May 3rd 2022. Cramping, intense bleeding, passing of a fetus.
Miscarriage of a 9 week pregnancy on May 3rd 2022. Cramping, intense bleeding, passing of a fetus.
|
||||||
| 2862299 | F | 09/30/2025 |
COVID19 |
MODERNA |
|
Illness
Illness
|
Patient was not sick as a dog next week after receiving the shot; This spontaneous case was reported...
Patient was not sick as a dog next week after receiving the shot; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient was not sick as a dog next week after receiving the shot) in a female patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Patient was not sick as a dog next week after receiving the shot). At the time of the report, ILLNESS (Patient was not sick as a dog next week after receiving the shot) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. Concomitant medication use information was not provided by reporter. Patient always gets a COVID-19 shot every year and was about to receive the vaccine next week. It was inquired whether advil, tylenol, or something else was recommended. It was wanted by the reporter to know what should be bought from the supermarket at the time of reporting so that the patient was not sick as a dog next week after receiving the shot. The patient could not remember what took last year. It was unknown if the patient experienced any additional symptoms/events. Treatment medication use information was not provided by reporter.
More
|
||||||||
| 2862301 | 11 | M | NC | 09/30/2025 |
FLU3 FLU3 FLU3 HEPA HEPA HEPA HPV9 HPV9 HPV9 MNQ MNQ MNQ TDAP TDAP TDAP VARCEL VARCEL VARCEL |
SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
UT8770NA UT8770NA UT8770NA J4K4X J4K4X J4K4X Y018398 Y018398 Y018398 U8573AA U8573AA U8573AA U8122AA U8122AA U8122AA Y019318 Y019318 Y019318 |
Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming ...
Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming at mouth, Musculoskeletal stiffness, Nervousness, Pallor, Tearfulness; Unresponsive to stimuli; Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming at mouth, Musculoskeletal stiffness, Nervousness, Pallor, Tearfulness; Unresponsive to stimuli; Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming at mouth, Musculoskeletal stiffness, Nervousness, Pallor, Tearfulness; Unresponsive to stimuli; Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming at mouth, Musculoskeletal stiffness, Nervousness, Pallor, Tearfulness; Unresponsive to stimuli; Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming at mouth, Musculoskeletal stiffness, Nervousness, Pallor, Tearfulness; Unresponsive to stimuli; Blood test, Computerised tomogram, Dyskinesia, Electrocardiogram, Fall; Foaming at mouth, Musculoskeletal stiffness, Nervousness, Pallor, Tearfulness; Unresponsive to stimuli
More
|
After last vaccine was administered, pt began leaning/falling backwards with eyes partially assisted...
After last vaccine was administered, pt began leaning/falling backwards with eyes partially assisted him in sitting upright. Pt then began displaying bilateral arms and legs stiffening, and pt was unresponsive. Pt then displayed full body jerking for approximately 5 seconds, remaining unresponsive. Foaming saliva was noted in the edge of his mouth. He was lowered onto his side on the exam table, in the recovery position. Additional staff arrived and 911 was called. Pt skin was pale, warm and moist. Pt quickly began responding and was alert and oriented to person and place. Pt was tearful and nervous. Pt remained in lying position on exam table. Mom and Dad both remained in the room, with Mom at the bedside. EMS first responders arrived and assumed care of pt. Pt was transported to hospital for further evaluation. Follow up on pt on 09/29/2025 when in facility d/t needed school physical. Pt and parents report child has been feeling well since 9/26/25. Pt appears well and is in no distress. Pt mother and father reported pt had CT scan, bloodwork and "they checked his heart" while being seen in the ER on 9/26/25. Parents were given instructions for pt to f/u with a provider if he experienced similar episode again.
More
|
||||||
| 2862302 | 62 | F | PA | 09/30/2025 |
FLU3 |
SEQIRUS, INC. |
ax5591B |
Blood glucose normal, Dizziness, Immediate post-injection reaction, Nausea, Palp...
Blood glucose normal, Dizziness, Immediate post-injection reaction, Nausea, Palpitations
More
|
Flu shot administered at 8:50am Immediately after injection pt began feeling lightheaded and having ...
Flu shot administered at 8:50am Immediately after injection pt began feeling lightheaded and having palpitations. VS: BP 160/90 HR 122 O2: 99% Glucose 115 LS clear- no stridor, no hives, Neuro check WNL Placed in trendelenberg. O2 applied. Orange juice given. Vagal maneuver attempted. HR was regular and began to slow to 80s HR remains WNL but pt continued to feel lightheaded and nauseous. EMS called and Pt transferred to ED at (withheld name) Medicine in stable condition, aox3, speaking in full uncompromised sentences, WNL neuro checks.
More
|
||||||
| 2862303 | 0.17 | F | KY | 09/30/2025 |
FLU3 |
SEQIRUS, INC. |
406996 |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
Flu vaccine given in error. Contraindicated, not approved under 6 months of age
Flu vaccine given in error. Contraindicated, not approved under 6 months of age
|
||||||
| 2862304 | 25 | F | PA | 09/30/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
3052669 3052669 |
Chills, Hyperhidrosis, Injection site swelling, Pain, Pruritus; Pyrexia
Chills, Hyperhidrosis, Injection site swelling, Pain, Pruritus; Pyrexia
|
Swelling in injection site, itchiness, fever lasting around 8 hours, chills, sweating, body aches
Swelling in injection site, itchiness, fever lasting around 8 hours, chills, sweating, body aches
|
||||||
| 2862306 | 56 | F | MI | 09/30/2025 |
FLU3 FLU3 PNC20 PNC20 |
SANOFI PASTEUR SANOFI PASTEUR PFIZER\WYETH PFIZER\WYETH |
U8767BA U8767BA MA2505 MA2505 |
Blister, Blister rupture, Peripheral swelling, Pyrexia, Rash; Scab; Blister, Bli...
Blister, Blister rupture, Peripheral swelling, Pyrexia, Rash; Scab; Blister, Blister rupture, Peripheral swelling, Pyrexia, Rash; Scab
More
|
patient states that when she woke up the next morning it was blistered. it has since popped and no...
patient states that when she woke up the next morning it was blistered. it has since popped and now has a scab on it. this will be for the Influenza vaccine. Prevnar 20 patient states that she had a low-grade fever and her arm swelled up. she stated there was a rash on half of the arm.
More
|
||||||
| 2862307 | 40 | F | VA | 09/30/2025 |
FLU3 |
SANOFI PASTEUR |
UT8770NA |
Erythema, Injection site paraesthesia, Injection site warmth, Pruritus, Urticari...
Erythema, Injection site paraesthesia, Injection site warmth, Pruritus, Urticaria
More
|
9/26/2025 @ approximately 3:15 pm received Sanofi Fluzone- regular dose. Initially noted warmth and ...
9/26/2025 @ approximately 3:15 pm received Sanofi Fluzone- regular dose. Initially noted warmth and tingling near on shoulder of arm that received vaccine in. Colleagues noted employee?s chest appeared red. Upon examining her shoulder and upper arms there were hives and she was itching. When came back to Health at Work clinic location at 1540 for assessment she was also noted to have small area of hives on left upper abdomen.Benadryl 25mg po @ 1541 Vitals stable and no progression of hives 1600. Cleared to leave at 1615.
More
|
||||||
| 2862309 | 9 | F | WV | 09/30/2025 |
MNP |
PFIZER\WYETH |
LT0075 |
No adverse event, Product administered to patient of inappropriate age
No adverse event, Product administered to patient of inappropriate age
|
No reported adverse reactions.
No reported adverse reactions.
|
||||||
| 2862310 | 74 | M | TX | 09/30/2025 |
COVID19 FLU3 PNC13 VARZOS |
MODERNA SEQIRUS, INC. PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
|
Condition aggravated, Neuropathy peripheral, Pain in extremity; Condition aggrav...
Condition aggravated, Neuropathy peripheral, Pain in extremity; Condition aggravated, Neuropathy peripheral, Pain in extremity; Condition aggravated, Neuropathy peripheral, Pain in extremity; Condition aggravated, Neuropathy peripheral, Pain in extremity
More
|
Severe pain in feet has neuropathy, but has always had no feeling numbness now severe pain
Severe pain in feet has neuropathy, but has always had no feeling numbness now severe pain
|
||||||
| 2862311 | 80 | F | FL | 09/30/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Extra dose administered
Extra dose administered
|
Patient received two doses of RSV.
Patient received two doses of RSV.
|
||||||
| 2862312 | 65 | F | NC | 09/30/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Nausea, Pain, Pyrexia, Swollen tongue, Tongue coated
Nausea, Pain, Pyrexia, Swollen tongue, Tongue coated
|
Fever, aches, nausea, white and swollen tongue
Fever, aches, nausea, white and swollen tongue
|
||||||
| 2862313 | 1.5 | M | OH | 09/30/2025 |
DTAP DTAP DTAP PNC21 PNC21 PNC21 |
SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
|
Crying, Fatigue, Food refusal, Gait disturbance, Gait inability; Injection site ...
Crying, Fatigue, Food refusal, Gait disturbance, Gait inability; Injection site mass, Injection site reaction, Injection site swelling, Lethargy, Pyrexia; Tremor; Crying, Fatigue, Food refusal, Gait disturbance, Gait inability; Injection site mass, Injection site reaction, Injection site swelling, Lethargy, Pyrexia; Tremor
More
|
Patient was administered two shots on September 19, 2025 - Tdap and Pneumococcal, one in each thigh....
Patient was administered two shots on September 19, 2025 - Tdap and Pneumococcal, one in each thigh. After he woke up from a nap around 2 pm, he had a low-grade fever (101), shaking, acted lethargic, would not eat, and would not walk on his legs. In addition, he had a mild rash on both legs, a hard lump on his left leg with some swelling. He would cry when moved and would just lie down. These same symptoms lasted for 3 days. When he finally started to walk again, he would with a limp and would still tire out quickly. By day 5 he was back to normal. He is only 1.5 years old.
More
|
||||||
| 2862314 | 92 | F | AR | 09/30/2025 |
COVID19 |
MODERNA |
8146670 |
COVID-19
COVID-19
|
hospitalized with COVID
hospitalized with COVID
|
โ | |||||
| 2862315 | 76 | F | GA | 09/30/2025 |
FLU3 |
SANOFI PASTEUR |
|
Rash
Rash
|
rash, 2 + weeks on right arm and traveling in patches down body on right hand side
rash, 2 + weeks on right arm and traveling in patches down body on right hand side
|
||||||
| 2862316 | 83 | F | NH | 09/30/2025 |
COVID19 |
MODERNA |
|
Pneumonia
Pneumonia
|
pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONI...
pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (pneumonia) in an 83-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine (Patient had received all the COVID-19 vaccines from Moderna since the earliest days of the pandemic). Past adverse reactions to the above products included No adverse effect with Moderna COVID-19 vaccine. On an unknown date, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. In 2025, the patient experienced PNEUMONIA (pneumonia) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from sometime in 2025 to sometime in 2025 due to PNEUMONIA. In 2025, PNEUMONIA (pneumonia) had resolved. No concomitant medications were reported. Patient had received all the COVID-19 vaccines from Moderna since the earliest days of the pandemic. However, when the time came in the spring of 2025 for the patient to get the second dose of the Spikevax vaccine for 2024-25, she was in the hospital with pneumonia. Then, the patient just waited longer to get her a second dose. Eventually, in Aug-2025, the reporter began to search for a pharmacy that still had some 2024-25 COVID-19 vaccines left. The reporter was able to find a pharmacy that had some Pfizer vaccines left for 2024-25. Since reporter did not know when the new vaccines would be available, the patient went ahead and got a second dose of a 2024-25 COVID vaccine (this time from Pfizer vaccine) in August. The reporter raised concern about how long the patient must wait before getting the 2025-26 COVID-19 vaccine from Moderna. It was reported that one local pharmacist described the time interval as 3 months, and another pharmacist described the time interval as 6 months, and reporter then asked about which one was correct. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported.; Reporter's Comments: The event of Pneumonia was assessed as not related to suspected vaccine due to lack of biological plausibility. Patient's advanced age was assessed as a confounding factor. The benefit-risk relationship of product is not affected by this report.
More
|
โ | |||||
| 2862317 | 42 | F | WI | 09/30/2025 |
COVID19 COVID19 HEP HEP IPV IPV |
MODERNA MODERNA GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR SANOFI PASTEUR |
3043335 3043335 MD9SL MD9SL X1D141M X1D141M |
Arthralgia, Immediate post-injection reaction, Mobility decreased, Muscular weak...
Arthralgia, Immediate post-injection reaction, Mobility decreased, Muscular weakness, Pain; Sleep disorder; Arthralgia, Immediate post-injection reaction, Mobility decreased, Muscular weakness, Pain; Sleep disorder; Arthralgia, Immediate post-injection reaction, Mobility decreased, Muscular weakness, Pain; Sleep disorder
More
|
Client reported that pain was "immediate" after receiving vaccine. Pain is reported as con...
Client reported that pain was "immediate" after receiving vaccine. Pain is reported as constant and sharp, but it is aggravated when client sleeps on that side/arm, or when client lifts or picks-up things. Pain is in right shoulder - client also reports "it feels like the needle is still there." Per client, it has continued to hurt over the past 9 months. Client reports only using/taking tylenol for pain relief. Client denies seeking medical attention for the arm/shoulder pain. Client had visible limited range of motion on that shoulder and weakness on the right arm. Both arms evaluated - no palpable lumps or visible discoloration or swelling. Client was instructed to follow-up with her provider.
More
|
||||||
| 2862318 | 60 | F | FL | 09/30/2025 |
COVID19 |
PFIZER\BIONTECH |
|
COVID-19, Leg amputation, Thrombosis
COVID-19, Leg amputation, Thrombosis
|
About a week after vaccination I got Covid and about a month later blood clots formed and I had left...
About a week after vaccination I got Covid and about a month later blood clots formed and I had left below knee amputation
More
|
โ | โ | โ | |||
| 2862319 | 56 | F | GA | 09/30/2025 |
FLU3 PNC20 TDAP |
SANOFI PASTEUR PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
u8823aa ma2523 4ya34 |
Injection site bruising, Injection site haemorrhage, Injection site swelling; In...
Injection site bruising, Injection site haemorrhage, Injection site swelling; Injection site bruising, Injection site haemorrhage, Injection site swelling; Injection site bruising, Injection site haemorrhage, Injection site swelling
More
|
patient's arm was swollen, raised bump at injection site, slightly bruised and bleeding more th...
patient's arm was swollen, raised bump at injection site, slightly bruised and bleeding more than usual. I applied pressure to stop the bleeding and it did stop bleeding. Slight bump remained. The patient was fine and left. No other symptoms.
More
|
||||||
| 2862320 | 67 | F | FL | 09/30/2025 |
PNC20 |
PFIZER\WYETH |
ma2523 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient got this Prevnar-20 in June 2023. We overlooked and gave it to her again on 9/28/2025. I spo...
Patient got this Prevnar-20 in June 2023. We overlooked and gave it to her again on 9/28/2025. I spoke to patient, and she was fine.
More
|
||||||
| 2862321 | 55 | M | MN | 09/30/2025 |
COVID19 COVID19 FLU3 FLU3 UNK UNK |
MODERNA MODERNA SEQIRUS, INC. SEQIRUS, INC. UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
3052583 3052583 948400 948400 948400 948400 |
Dyspnoea, Electrocardiogram, Rash; Dyspnoea, Rash, Urticaria; Dyspnoea, Electroc...
Dyspnoea, Electrocardiogram, Rash; Dyspnoea, Rash, Urticaria; Dyspnoea, Electrocardiogram, Rash; Dyspnoea, Rash, Urticaria; Dyspnoea, Electrocardiogram, Rash; Dyspnoea, Rash, Urticaria
More
|
Client reported a severe reaction with rash over his whole body and difficulty breathing requiring ...
Client reported a severe reaction with rash over his whole body and difficulty breathing requiring a visit to Urgent care to receive steroids.
More
|
||||||
| 2862322 | 67 | F | FL | 09/30/2025 |
UNK |
UNKNOWN MANUFACTURER |
390104 |
Blood pressure increased, Dizziness, Immediate post-injection reaction, Renal fu...
Blood pressure increased, Dizziness, Immediate post-injection reaction, Renal function test normal
More
|
Immediate spike in blood pressure, dizziness and feeling faint upon standing. Remained in office un...
Immediate spike in blood pressure, dizziness and feeling faint upon standing. Remained in office until BP normalized.
More
|
||||||
| 2862324 | 1 | M | GA | 09/30/2025 |
FLU3 FLU3 HEPA HEPA MMR MMR VARCEL VARCEL |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
4F2AJ 4F2AJ Z003748 Z003748 Z003402 Z003402 Z008195 Z008195 |
Crying, Cyanosis, Immediate post-injection reaction, Lethargy, Oxygen saturation...
Crying, Cyanosis, Immediate post-injection reaction, Lethargy, Oxygen saturation decreased; Somnolence; Crying, Cyanosis, Immediate post-injection reaction, Lethargy, Oxygen saturation decreased; Somnolence; Crying, Cyanosis, Immediate post-injection reaction, Lethargy, Oxygen saturation decreased; Somnolence; Crying, Cyanosis, Immediate post-injection reaction, Lethargy, Oxygen saturation decreased; Somnolence
More
|
Patient in for 12 month WCC appointment 9/29/25 and received routine vaccines: MMR, VVX, Hep A + Flu...
Patient in for 12 month WCC appointment 9/29/25 and received routine vaccines: MMR, VVX, Hep A + Flu. He cried immediately then stopped crying and lips turned blue. PCP evaluated patient and cyanosis resolved but patient was still very sleepy & lethargic. Difficult to waken.
More
|
||||||
| 2862325 | 71 | F | TN | 09/30/2025 |
PNC20 |
PFIZER\WYETH |
LX4482 |
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
patient received vaccine only three years after first dose, which is less than CDC recommends
patient received vaccine only three years after first dose, which is less than CDC recommends
|
||||||
| 2862326 | 12 | F | AL | 09/30/2025 |
HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
Y012776 Y012776 |
Balance disorder, Dizziness, Headache, Hypotension, Influenza virus test negativ...
Balance disorder, Dizziness, Headache, Hypotension, Influenza virus test negative; Injection site urticaria, Nausea, Pain, Pyrexia, Urticaria
More
|
She developed headache and dizziness right after getting the vaccine. Observed for 30 minutes and f...
She developed headache and dizziness right after getting the vaccine. Observed for 30 minutes and felt better. Developed fever on the way home to 101. That evening had low blood pressure until 8PM. Hives around injection site and down her arm. Continued with nausea and dizziness overnight. Morning of 9/23 she felt unsteady and continued to have nausea and dizziness. Also had body aches. Rechecked in clinic - flu negative.
More
|
||||||
| 2862327 | 0.83 | F | WA | 09/30/2025 |
DTAPIPVHIB PNC15 |
SANOFI PASTEUR MERCK & CO. INC. |
UK232AB Z010141 |
Inappropriate schedule of product administration; Inappropriate schedule of prod...
Inappropriate schedule of product administration; Inappropriate schedule of product administration
More
|
ADVERSE TREATMENT- VACCINE BOOSTERS ADMINISTERED IN ERROR. PATIENT WAS NOT YET DUE. PARENTS ADVISED
ADVERSE TREATMENT- VACCINE BOOSTERS ADMINISTERED IN ERROR. PATIENT WAS NOT YET DUE. PARENTS ADVISED
|
||||||
| 2862328 | 73 | F | MN | 09/30/2025 |
FLUN3 |
MEDIMMUNE VACCINES, INC. |
WF2584B |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
NONE - NOT AGE APPROPRIATE ADMINISTRATION
NONE - NOT AGE APPROPRIATE ADMINISTRATION
|
||||||
| 2862329 | 87 | F | OH | 09/30/2025 |
COVID19 |
MODERNA |
3052736 |
Injection site urticaria, Urticaria
Injection site urticaria, Urticaria
|
Pt woke up the following morning with hives around the injection site which spread to her neck and c...
Pt woke up the following morning with hives around the injection site which spread to her neck and chest. At time of reporting the hives were getting better
More
|
||||||
| 2862330 | 46 | M | CA | 09/30/2025 |
FLU3 |
SEQIRUS, INC. |
948396 |
Flushing, Hypersensitivity, Paraesthesia oral, Urticaria
Flushing, Hypersensitivity, Paraesthesia oral, Urticaria
|
Allergic reaction - hives, flushing, tingling lips about 15 minutes after vax - was taken to the ED ...
Allergic reaction - hives, flushing, tingling lips about 15 minutes after vax - was taken to the ED on site for further treatment
More
|
||||||
| 2862331 | 72 | M | LA | 09/30/2025 |
COVID19 COVID19 UNK UNK |
MODERNA MODERNA UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Cardiac monitoring normal, Chronic inflammatory demyelinating polyradiculoneurop...
Cardiac monitoring normal, Chronic inflammatory demyelinating polyradiculoneuropathy, Hypoaesthesia, Immunoglobulin therapy, Laboratory test; Limb discomfort, Loss of consciousness; Cardiac monitoring normal, Chronic inflammatory demyelinating polyradiculoneuropathy, Hypoaesthesia, Immunoglobulin therapy, Laboratory test; Limb discomfort, Loss of consciousness
More
|
About 3 days after being vaccinated. He started having numbness in both hands and both legs as they ...
About 3 days after being vaccinated. He started having numbness in both hands and both legs as they were numb. He thought the this would go away after a few days but they continued to be numb. He passed out when leaving the gym but then came to. The ambulance came to check vitals and he was let go because they were back to normal. He went to his doctor and was given a heart monitor to wear for 6 days. Results were negative. His hand and legs became heavier. He was referred to Dr. He was diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy. He was sent to a hematologist. He was put on B12 injections and supplements. He started getting some strength back where he can start doing things again. He still has the heaviness in the limbs and continues IVIG treatments every three weeks.
More
|
โ | |||||
| 2862333 | 87 | M | 09/30/2025 |
COVID19 |
MODERNA |
|
Atrial fibrillation
Atrial fibrillation
|
afib; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FIBRIL...
afib; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FIBRILLATION (afib) in an 87-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Emphysema. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced ATRIAL FIBRILLATION (afib) (seriousness criterion medically significant). At the time of the report, ATRIAL FIBRILLATION (afib) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. Concomitant medication was not reported. It was reported that a patient visited his GP who had been his doctor for the past 10 years and was advised not to receive any COVID-19 vaccine this year. He received twice a year, and from the start of COVID in 2019-2020 he had taken Moderna shots every time. Patient's GP told him that what was happening was that the COVID shot was metastasizing, it was mentioned that this might be the incorrect word, with the previous shots and could cause their own little malady that affects the heart and lungs. It was reported that, patient was inquiring whether he should receive a COVID-19 vaccine. Patient suffered from emphysema and had been receiving Moderna's COVID-19 vaccines in recent years. Patient's doctor informed him that receiving a COVID-19 vaccine this year could potentially exacerbate his condition and create complications. It was unknown if the patient experienced any additional symptoms/events. Treatment medication was not reported. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 18-Sep-2025: Live significant follow-up received: Reporter name, medical history and reference id added; Reporter's Comments: The benefit -risk relationship of product is not affected by this report.
More
|
|||||||
| 2862334 | 51 | F | MN | 09/30/2025 |
FLU3 FLU3 PNC20 PNC20 |
SEQIRUS, INC. SEQIRUS, INC. PFIZER\WYETH PFIZER\WYETH |
407001 407001 MA2505 MA2505 |
Chills, Erythema, Fatigue, Pain in extremity, Peripheral swelling; Pyrexia; Chil...
Chills, Erythema, Fatigue, Pain in extremity, Peripheral swelling; Pyrexia; Chills, Erythema, Fatigue, Pain in extremity, Peripheral swelling; Pyrexia
More
|
left arm sore, red, swollen - fever, aches, chills, exhaustion. 48 hours post injection redness spre...
left arm sore, red, swollen - fever, aches, chills, exhaustion. 48 hours post injection redness spread on arm
More
|
||||||
| 2862335 | 4 | M | IL | 09/30/2025 |
DTAPIPV DTAPIPV FLUN3 FLUN3 MMRV MMRV |
SANOFI PASTEUR SANOFI PASTEUR MEDIMMUNE VACCINES, INC. MEDIMMUNE VACCINES, INC. MERCK & CO. INC. MERCK & CO. INC. |
U8209CB U8209CB YH3387C YH3387C Z009076 Z009076 |
Injection site erythema, Injection site pain, Injection site reaction, Injection...
Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth; Livedo reticularis; Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth; Livedo reticularis; Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth; Livedo reticularis
More
|
Left arm with significant swelling, from a few inches above elbow up to his shoulder. It is red, m...
Left arm with significant swelling, from a few inches above elbow up to his shoulder. It is red, mottled, and warm to touch and running fevers around 100. Some tenderness to the site. Has full range of motion.
More
|
||||||
| 2862336 | 82 | F | IA | 09/30/2025 |
FLU3 |
SEQIRUS, INC. |
407252 |
Erythema, Localised infection, Product administered at inappropriate site
Erythema, Localised infection, Product administered at inappropriate site
|
Vaccine administered low. Patient presented with redness and infection in left arm. Antibiotics pr...
Vaccine administered low. Patient presented with redness and infection in left arm. Antibiotics prescribed and started on 09/30; Patient reported incident
More
|
||||||
| 2862337 | 51 | F | CA | 09/30/2025 |
PNC20 |
PFIZER\WYETH |
MA2523 |
Injection site rash, Injection site swelling
Injection site rash, Injection site swelling
|
Rash and swelling on the injection site Right deltoid
Rash and swelling on the injection site Right deltoid
|
||||||
| 2862338 | 66 | F | CO | 09/30/2025 |
RSV RSV TDAP TDAP |
PFIZER\WYETH PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
LN5470 LN5470 H4K3S H4K3S |
Dizziness, Full blood count, Headache, Injection site erythema, Injection site p...
Dizziness, Full blood count, Headache, Injection site erythema, Injection site pain; Injection site swelling, Injection site warmth, Metabolic function test, Ultrasound Doppler normal; Dizziness, Full blood count, Headache, Injection site erythema, Injection site pain; Injection site swelling, Injection site warmth, Metabolic function test, Ultrasound Doppler normal
More
|
Patient received both RSV and Tdap vaccinations in the same arm on 9/17. On 9/29 patient woke up to ...
Patient received both RSV and Tdap vaccinations in the same arm on 9/17. On 9/29 patient woke up to a red, swollen, and tender/hot area on the upper left arm, and was feeling dizziness and headache. Patient went into the ER and was found have a BP if 199/80 at that time. the ER completed full blood panel and ultrasound of the arm was taken with no findings. Patient was sent home after 3 hours and told to monitor blood pressure. Upon returning to the pharmacy on 9/30, her BP was at 168/118 and patient was instructed to set up follow-up appointment with primary care physician
More
|